Ann Tripp - Hanover Insurance President
| THG Stock | USD 161.73 1.87 1.14% |
President
Ms. Ann Kirkpatrick Tripp is Senior Vice President, Chief Investment Officer and President, Opus Investment Management, Inc, a subsidiary of the Company. Ms. Tripp was Chief Investment Officer and President of Opus Investment Management, Inc. since 2006. She joined the Company in 1987, and prior to becoming our Chief Investment Officer, served in a variety of increasingly senior roles within our investment department. Ms. Tripp is also the Investment Officer of the Hanover Insurance Group Foundation and serves on the board and subcommittees of several area nonprofit organizations. since 2019.
| Age | 61 |
| Tenure | 5 years |
| Address | 440 Lincoln Street, Worcester, MA, United States, 01653 |
| Phone | 508 855 1000 |
| Web | https://www.hanover.com |
Hanover Insurance Management Efficiency
The company has Return on Asset of 0.0215 % which means that on every $100 spent on assets, it made $0.0215 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1463 %, implying that it generated $0.1463 on every 100 dollars invested. Hanover Insurance's management efficiency ratios could be used to measure how well Hanover Insurance manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Hanover Insurance's Net Tangible Assets are most likely to increase significantly in the upcoming years.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Heather Wietzel | Horace Mann Educators | N/A | |
| James McKinney | Kemper | 44 | |
| Peter Enns | Chubb | 58 | |
| Liam Caffrey | White Mountains Insurance | 51 | |
| John Dugenske | The Allstate | 53 | |
| Joseph Wayland | Chubb | 63 | |
| Tim Stonehocker | Kemper | N/A | |
| Robert Seelig | White Mountains Insurance | 55 | |
| Juan Ortega | Chubb | 49 | |
| Mojgan Lefebvre | The Travelers Companies | 58 | |
| Elizabeth Aguinaga | CNA Financial | 43 | |
| Maria Olivo | The Travelers Companies | 55 | |
| John Boschelli | Kemper | 55 | |
| William Folmar | Donegal Group B | 65 | |
| Mark Wilcox | Selective Insurance Group | 56 | |
| Lori Niederst | Progressive Corp | 51 | |
| Rhonda Ferguson | The Allstate | 50 | |
| Jose Gonzalez | CNA Financial | 52 | |
| Michael Klein | The Travelers Companies | 56 | |
| Scott Lindquist | CNA Financial | 57 | |
| Todd Bryant | RLI Corp | 52 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0215 |
Hanover Insurance Leadership Team
Elected by the shareholders, the Hanover Insurance's board of directors comprises two types of representatives: Hanover Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hanover. The board's role is to monitor Hanover Insurance's management team and ensure that shareholders' interests are well served. Hanover Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hanover Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Medina, President - Professional Liability | ||
| Scott Grieco, Chief Product and Underwriting officer | ||
| P Condron, Independent Chairman of the Board | ||
| Martin Hughes, Independent Director | ||
| John Roche, Senior Vice President and Presidentident - Business Insurance | ||
| Harriett Taggart, Independent Director | ||
| Cynthia Egan, Independent Vice Chairman of the Board | ||
| Jeffrey Farber, Chief Financial Officer, Executive Vice President, Senior Finance Officer | ||
| Ann Tripp, Executive Vice President, Chief Investment Officer, Treasurer and President, Opus Investment Management, Inc. | ||
| Matthew Mitchell, President - Hanover's middle market business | ||
| James Kelley, President - Hanover Specialty Industrial Property | ||
| Jennifer Luisa, VP Officer | ||
| Richard Lavey, Senior Vice President Chief Marketing and Distribution Officer | ||
| Theodore Bunting, Independent Director | ||
| Gayle Falvey, VP COO | ||
| Warren Barnes, Senior Vice President and Corporate Controller and Principal Accounting Officer | ||
| Mark Welzenbach, Executive Vice President, Chief Claims Officer | ||
| Lindsay Greenfield, Senior Officer | ||
| Wendell Knox, Independent Director | ||
| Willard Lee, Senior Vice President, Chief Technology Innovation Officer, Chief Information Officer | ||
| Daniel Henry, Independent Director | ||
| Mark Berthiaume, Executive Vice President, Chief Technology Innovation Officer | ||
| Denise Lowsley, Chief Human Resource Officer, Executive Vice President | ||
| J Condrin, Independent Director | ||
| Dennis Kerrigan, Executive Vice President General Counsel, Assistant Secretary | ||
| Mina Rona, President Sciences | ||
| Kathleen Lane, Independent Director | ||
| Oksana Lukasheva, IR Contact Officer | ||
| Joseph Ramrath, Independent Director | ||
| Jane Carlin, Independent Director | ||
| Kevin Bradicich, Independent Director | ||
| Bryan Salvatore, Executive Vice President and Presidentident - Specialty |
Hanover Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hanover Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0215 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 6.25 B | ||||
| Shares Outstanding | 36.03 M | ||||
| Shares Owned By Insiders | 0.76 % | ||||
| Shares Owned By Institutions | 88.38 % | ||||
| Number Of Shares Shorted | 248.28 K | ||||
| Price To Earning | 18.15 X |
Currently Active Assets on Macroaxis
When determining whether Hanover Insurance is a strong investment it is important to analyze Hanover Insurance's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Hanover Insurance's future performance. For an informed investment choice regarding Hanover Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Hanover Insurance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hanover Insurance. If investors know Hanover will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hanover Insurance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 10.656 | Dividend Share 3.4 | Earnings Share 10.09 | Revenue Per Share 172.438 | Quarterly Revenue Growth 0.032 |
The market value of Hanover Insurance is measured differently than its book value, which is the value of Hanover that is recorded on the company's balance sheet. Investors also form their own opinion of Hanover Insurance's value that differs from its market value or its book value, called intrinsic value, which is Hanover Insurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hanover Insurance's market value can be influenced by many factors that don't directly affect Hanover Insurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hanover Insurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hanover Insurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hanover Insurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.